Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.26087 | 85 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.35861 | 85 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.8682 | 88 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.87208 | 87 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.6315 | 86 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.61924 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.5659 | 80 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.13817 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.74575 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.24434 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.8084 | 81 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.5312 | 86 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.2207 | 84 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.19394 | 84 |